J103-0023 Screening compound: N-{4H,5H,6H,7H,8H-cyclohepta[d][1,3]thiazol-2-yl}-2-(3-oxo-2,3,5,6,7,8-hexahydrocinnolin-2-yl)acetamide

J103-0023 Screening compound: N-{4H,5H,6H,7H,8H-cyclohepta[d][1,3]thiazol-2-yl}-2-(3-oxo-2,3,5,6,7,8-hexahydrocinnolin-2-yl)acetamide
J103-0023 Screening compound: N-{4H,5H,6H,7H,8H-cyclohepta[d][1,3]thiazol-2-yl}-2-(3-oxo-2,3,5,6,7,8-hexahydrocinnolin-2-yl)acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound J103-0023
N-{4H,5H,6H,7H,8H-cyclohepta[d][1,3]thiazol-2-yl}-2-(3-oxo-2,3,5,6,7,8-hexahydrocinnolin-2-yl)acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

J103-0023

Molecular Formula

C18H22N4O2S (C18 H22 N4 O2 S)

Compound Name

N-{4H,5H,6H,7H,8H-cyclohepta[d][1,3]thiazol-2-yl}-2-(3-oxo-2,3,5,6,7,8-hexahydrocinnolin-2-yl)acetamide

IUPAC name

N-{4H5H6H7H8H-cyclohepta[d][13]thiazol-2-yl}-2-(3-oxo-235678-hexahydrocinnolin-2-yl)acetamide

SMILES

O=C(CN1N=C(CCCC2)C2=CC1=O)Nc1nc(CCCCC2)c2s1

InChI

InChI=1S/C18H22N4O2S/c23-16(20-18-19-14-8-2-1-3-9-15(14)25-18)11-22-17(24)10-12-6-4-5-7-13(12)21-22/h10H,1-9,11H2,(H,19,20,23)

InChI Key

XPYGWIDICYWURH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD18797265

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

358.46

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.286

Distribution Coefficient, logD

3.253

Water Solubility, LogSw

-3.49

Polar Surface Area

63.181

Acid Dissociation Constant (pKa)

8.50

Base Dissociation Constant (pKb)

2.11

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

55.60

J103-0023 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with J103-0023 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound J103-0023?
Check Price and Availability of J103-0023, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of J103-0023 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for J103-0023
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for J103-0023
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of J103-0023 available by request